Abstract: A fourth allotrope of carbon, an acetylenic carbon allotrope, is described. The acetylenic carbon allotropes of the present invention are more soluble than the other known carbon allotropes in many common organic solvents and possesses other desirable characteristics, e.g. high electron density, ability to burn cleanly, and electrical conductive properties. Many uses for this fourth allotrope are described herein.
Abstract: Therapeutic compounds and methods for inhibiting amyloid deposition in a subject, whatever its clinical setting, are described. Amyloid deposition is inhibited by the administration to a subject of an effective amount of a therapeutic compound comprising an anionic group and a carrier molecule, or a pharmaceutically acceptable salt thereof, such that an interaction between an amyloidogenic protein and a basement membrane constituent is inhibited. Preferred anionic groups are sulfonates and sulfates. Preferred carrier molecules include carbohydrates, polymers, peptides, peptide derivatives, aliphatic groups, alicyclic groups, heterocyclic groups, aromatic groups and combinations thereof.
Type:
Grant
Filed:
March 15, 1995
Date of Patent:
July 1, 1997
Assignee:
Queen's University of Kingston
Inventors:
Robert Kisilevsky, Walter Szarek, Donald Weaver
Abstract: Methods and systems for treatment of vesicoureteral reflux are disclosed in which a detachable balloon catheter is incorporated into a endoscopic instrument, such as a cystoscopic needle. The needle is directed through the cystoscope and inserted into the subureteral region of the refluxing ureter. A catheter or similar delivery device is inserted into the subureteral region, carrying a balloon. The balloon is then inflated, preferably filled with an inert biocompatible material, and then sealed. After inflation, the balloon is detached and left in the pocket such that the junction of the bladder and ureter is reconfigured to prevent reflux.